Disclosures for "White Matter Hyperintensities in Brains of Patients with Long-covid"
-
Dr. Atik has nothing to disclose.
-
Scott Przybelski has nothing to disclose.
-
The institution of Dr. Zeydan has received research support from National Institutes of Health.
-
Dr. Kantarci has nothing to disclose.
-
Mrs. Kendall-Thomas has nothing to disclose.
-
Matthew Senjem has received stock or an ownership interest from Align Technology, Inc.. Matthew Senjem has received stock or an ownership interest from Inovio Biomedical Corp.. Matthew Senjem has received stock or an ownership interest from Johnson & Johnson. Matthew Senjem has received stock or an ownership interest from Mesa Laboratories, Inc.. Matthew Senjem has received stock or an ownership interest from Nvidia Inc.. Matthew Senjem has received stock or an ownership interest from LHC Group, Inc.. Matthew Senjem has received stock or an ownership interest from Natus Medical Incorporated. Matthew Senjem has received stock or an ownership interest from Varex Imaging Corporation. Matthew Senjem has received personal compensation in the range of $100,000-$499,999 for serving as a IT Technical Specialist II with Mayo Clinic.
-
Dr. Silva has nothing to disclose.
-
An immediate family member of Dr. Joers has received personal compensation in the range of $500,000-$999,999 for serving as an officer or member of the Board of Directors for Gillette Children's Specialty Healthcare.
-
Mrs. Gundry has nothing to disclose.
-
Rev. Lorente has nothing to disclose.
-
Mr. Thotland has nothing to disclose.
-
Dr. Deelchand has nothing to disclose.
-
Dr. Park has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Li has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vertex. The institution of Dr. Li has received research support from Argenx.
-
Dr. Manousakis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stealth Biotherapeutics. Dr. Manousakis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Manousakis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Manousakis has received research support from Marzolf foundation.
-
Dr. Metzler has nothing to disclose.
-
Prof. Lenglet has stock in Roche Holding AG. Prof. Lenglet has stock in GSK plc. The institution of Prof. Lenglet has received research support from NIH. The institution of Prof. Lenglet has received research support from NSF. The institution of Prof. Lenglet has received research support from Friedreich Ataxia Research Alliance. The institution of Prof. Lenglet has received research support from National Ataxia Foundation. The institution of Prof. Lenglet has received research support from Minnesota Office of Higher Education. The institution of Prof. Lenglet has received research support from FDA. The institution of Prof. Lenglet has received research support from USU/DOD/Geneva Foundation. Prof. Lenglet has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Eberly has nothing to disclose.
-
Dr. Juttukonda has nothing to disclose.
-
David H. Salat has or had stock in Niji.David H. Salat has or had stock in Smart Ion. The institution of David H. Salat has received research support from Renew.
-
An immediate family member of Dr. Sherman has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Pieris Pharmaceuticals. Dr. Sherman has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Keches Law. An immediate family member of Dr. Sherman has stock in Deciphera Pharmaceuticals.
-
Dr. Pollak has nothing to disclose.
-
Dr. Harrold has nothing to disclose.
-
Dr. Mukerji has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. Dr. Mukerji has or had stock in Gilead Science.Dr. Mukerji has or had stock in Ranpack.Dr. Mukerji has or had stock in Snowflake. An immediate family member of Dr. Mukerji has or had stock in Amgen. The institution of Dr. Mukerji has received research support from NIH. The institution of Dr. Mukerji has received research support from Massachusetts General Hospital.
-
Sevil Yasar, MD, PhD has nothing to disclose.
-
Ms. Nabi has nothing to disclose.
-
Dr. Rehman has nothing to disclose.
-
Author has nothing to disclose
-
Dr. Gillani has nothing to disclose.
-
Ms. Flores has nothing to disclose.
-
Author has nothing to disclose
-
An immediate family member of Dr. Ashizawa has received personal compensation for serving as an employee of Biopath Holdings. The institution of Dr. Ashizawa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UniQure. The institution of Dr. Ashizawa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cadence. Dr. Ashizawa has received personal compensation in the range of $0-$499 for serving as a Consultant for Astellas. The institution of Dr. Ashizawa has received research support from NIH. The institution of Dr. Ashizawa has received research support from National Ataxia Foundation. The institution of Dr. Ashizawa has received research support from Myotonic Dystrophy Foundation. The institution of Dr. Ashizawa has received research support from Biogen.
-
Author has nothing to disclose
-
Dr. Ratai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aletheia. Dr. Ratai has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BrainSpec.
-
Dr. Oz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. The institution of Dr. Oz has received research support from Biogen. Dr. Oz has received intellectual property interests from a discovery or technology relating to health care. Dr. Oz has a non-compensated relationship as a Medical Research Advisory Board with National Ataxia Foundation that is relevant to AAN interests or activities. Dr. Oz has a non-compensated relationship as a Scientific Advisory Board with BrainSpec that is relevant to AAN interests or activities.
-
The institution of Dr. Kantarci has received research support from Eli Lilly. The institution of Dr. Kantarci has received research support from NIH. The institution of Dr. Kantarci has received research support from ADDF. The institution of Dr. Kantarci has received research support from Eisai. The institution of Dr. Kantarci has received research support from BioArctic.